newsfilter
← Latest News
PR Newswire·

Ribo and Madrigal Reach First Major Milestone in Advancing Novel siRNA Therapies for MASH

Suzhou Ribo Life Science Co., Ltd. (06938.HK), and its subsidiary Ribocure Pharmaceuticals AB (collectively referred to as "Ribo"), in collaboration...